Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

1(50.0%)

N/A

1(50.0%)

2Total

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06688357Not ApplicableCompleted

Revitalize Cognition: Near Infrared Stimulation in Parkinson Patients

Role: collaborator

NCT01351467Completed

Web-based Genetic Research on Parkinson's Disease

Role: collaborator

NCT02016092Unknown

Biomarker Discovery in Parkinson's Disease

Role: lead

NCT01007630Phase 4Unknown

A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients

Role: lead

NCT01674998Unknown

Understanding the Natural History of REM Sleep Behavior Disorder

Role: lead

NCT00282802Unknown

Twins and the Risk of Parkinson's Disease: A Clinical and Imaging Study

Role: lead

All 6 trials loaded